Safehold stock price target cut to $32 at JMP Securities
JMP Securities adjusted its outlook on Safehold (NYSE:SAFE), reducing the real estate investment trust's price target from $35.00 to $32.00, while keeping a Market Outperform rating on the shares. The ...
techtimes22d
The Role of Assumptions in Statistical Model Selection
Abstract: Assumptions play a pivotal role in the selection and efficacy of statistical models, as unmet assumptions can lead to flawed conclusions and impact decision-making. In both traditional ...
JMP Securities Sticks to Their Buy Rating for Rallybio (RLYB)
JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on Rallybio (RLYB – Research Report) today and set a price target of $7.00.
JMP Securities Remains a Buy on MGM Resorts (MGM)
In a report released today, Jordan Bender from JMP Securities reiterated a Buy rating on MGM Resorts (MGM – Research Report), with a price ...
The New England Journal of Medicine27d
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer
Patients with human epidermal growth factor receptor 2 (HER2)–positive early breast cancer with residual invasive disease after neoadjuvant systemic therapy have a high risk of recurrence and death.
JMP Securities maintains Enanta stock with $21 target
JMP Securities reiterated a Market Outperform rating on Enanta Pharmaceuticals (NASDAQ:ENTA) shares with a consistent price target of $21.00. The firm's analysis highlighted the company's solid ...
The American Journal of Managed Care5d
Personalized CLL Therapy With MRD Guidance Improves Survival Outcomes
A study showed that using measurable residual disease (MRD) to guide ibrutinib-venetoclax therapy significantly improved ...
BBC19d
In Pictures
A selection of news photographs from around the world. Ian Wood put up a Banksy-style design in the hope of an 'art-imitates-life' photo op Marco Sanges' One Step Closer collection goes on display ...